Free the news
ThinkPol
Health

Two 'forever chemicals' linked to higher risk of aggressive breast cancer in large NIH study

By ThinkPol · · 3 min read

Worn non-stick frying pan examined under a magnifying glass
Dreamstime

Women with the highest blood levels of two long-lived "forever chemicals" were more likely to go on to develop an aggressive type of breast cancer, according to a large U.S. study led by researchers at the National Institutes of Health.

The study, published in the Journal of Clinical Oncology, found that PFOA and PFOS were linked to a higher risk of estrogen receptor-negative (ER-negative) breast cancer. This type of tumour does not need the hormone estrogen to grow, tends to be harder to treat and has few known risk factors. Neither chemical was clearly linked to breast cancer overall.

Blood drawn years before diagnosis

The researchers drew on the Sister Study, which has followed more than 50,000 American women since they enrolled between 2003 and 2009. All were free of breast cancer when they joined, and each had a sister or half-sister who had been diagnosed with the disease.

The team measured 17 different PFAS (per- and polyfluoroalkyl substances) in blood samples collected when the women enrolled, years before any diagnosis. They then compared 1,609 women who later developed breast cancer with a comparison group of 2,269 participants. To make sure there were enough of the rarer aggressive cases to study, they deliberately oversampled women with ER-negative tumours. To reduce the chance that undiagnosed cancer was skewing the results, they also excluded the first two years of follow-up.

What they found

Women in the top quarter of PFOS levels had a 93 per cent higher rate of ER-negative breast cancer than women in the bottom quarter. For PFOA, the highest-exposed quarter had a 67 per cent higher rate. A third compound, N-MeFOSAA, showed a weaker link that fell just short of statistical significance.

Not every chemical pointed the same way. One compound, PFTrDA, was associated with a lower risk of ER-negative tumours, which the authors say could be a real effect or could reflect other, unmeasured factors. Another, PFOSA, was linked to a modestly higher risk of the more common, hormone-sensitive breast cancers, but it was detected in fewer than seven per cent of women, so the authors urge caution.

For 15 of the 17 chemicals, there was essentially no link with breast cancer overall. The combined mixture of all PFAS also showed no clear effect, which suggests only a few specific compounds may matter.

Backed by earlier research

The team also pooled their results with six other studies that measured PFAS in blood before diagnosis. In that meta-analysis, PFOA was again associated with a higher risk of ER-negative breast cancer, and the evidence for PFOS pointed the same way but was less certain.

Because the links were concentrated in tumours that don't respond to hormones, the authors suggest PFAS may promote cancer through mechanisms unrelated to estrogen, such as changes to how genes are switched on and off, or suppression of the immune system.

"Our findings, which we confirmed using a meta-analysis of prior research, indicate that certain legacy PFAS, including PFOA and PFOS, are associated with a higher risk of ER-negative breast cancer, a more aggressive tumor type with few known risk factors," said NIH investigator Alexandra White, who led the study.

Old chemicals, still in our blood

PFOA and PFOS were once widely used in non-stick cookware, stain- and water-repellent fabrics, food packaging and firefighting foam. Both have largely been phased out and replaced with other PFAS, but they break down so slowly that measurable amounts remain in most people's bodies.

"Although PFAS are persistent in the environment and in our bodies, exposure to them is still potentially modifiable," said first author Che-Jung Chang, a former NIH research fellow now at the research organization DLH.

Caveats

The study shows an association, not proof that the chemicals cause cancer. Because every participant had a sister with breast cancer, the findings may not apply equally to all women. Some subgroups, including Black women with ER-negative tumours, were too small to draw firm conclusions.

The researchers say the next steps are to study populations with heavier PFAS exposure and higher rates of ER-negative breast cancer, and to look at the newer replacement PFAS, whose cancer risks remain poorly understood.

Source: Chang, C.-J., Pullella, K., Keil, A. P., Mullins, C. E., Chang, V. C., Young, A. S., Weil, J., Cardelino, M., Byun, J., Jones, D. P., Hu, X., Walker, D. I., & White, A. J., "Per- and Polyfluoroalkyl Substance Exposure and Breast Cancer Incidence in the Sister Study," Journal of Clinical Oncology (2026). doi:10.1200/JCO-26-00318; NIH news release.

Front PageHealth#PFAS#Forever chemicals#Breast cancer#PFOA#PFOS#National Institutes of Health